Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (221-230 of 356) with videos related to

Pageof 36
Sort By:
BMC Infectious Diseases|March 6, 2019
Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unitRiccardo Inchingolo, Giuliana Pasciuto, Daniele Magnini, et al.
The Lancet. Respiratory Medicine|July 1, 2017
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?Kerri A Johannson, Irina Strâmbu, Claudia Ravaglia, et al.
Infectious Diseases (London, England)|June 2, 2020
Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?Andrea Bellieni, Enrica Intini, Eleonora Taddei, et al.
The European Respiratory Journal|December 23, 2018
Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot studyGiacomo Sgalla, Anna Rita Larici, Nicola Sverzellati, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2005
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infectionGiovanni Ferrara, Monica Losi, Marisa Meacci, et al.
The Lancet. Respiratory Medicine|January 16, 2023
Treatable traits in interstitial lung diseases: a call to actionFrancesco Amati, Paolo Spagnolo, Justin M Oldham, et al.
Respiratory Research|March 17, 2021
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseasesVincent Cottin, Luca Richeldi, Ivan Rosas, et al.
Respiratory Research|October 23, 2023
Walking the path of treatable traits in interstitial lung diseasesFrancesco Amati, Paolo Spagnolo, Christopher J Ryerson, et al.
The Lancet. Respiratory Medicine|February 8, 2018
Diagnostic criteria for idiopathic pulmonary fibrosis - Authors' replyDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
Infectious Disease Reports|April 25, 2025
Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case SeriesMaria Angela Licata, Giorgio Monteleone, Enrico Schiavi, et al.
Pageof 36

Showing results (221-230 of 356) with videos related to

Sort By:
Pageof 36
BMC Infectious Diseases|March 6, 2019
Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unitRiccardo Inchingolo, Giuliana Pasciuto, Daniele Magnini, et al.
The Lancet. Respiratory Medicine|July 1, 2017
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?Kerri A Johannson, Irina Strâmbu, Claudia Ravaglia, et al.
Infectious Diseases (London, England)|June 2, 2020
Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?Andrea Bellieni, Enrica Intini, Eleonora Taddei, et al.
The European Respiratory Journal|December 23, 2018
Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot studyGiacomo Sgalla, Anna Rita Larici, Nicola Sverzellati, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2005
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infectionGiovanni Ferrara, Monica Losi, Marisa Meacci, et al.
The Lancet. Respiratory Medicine|January 16, 2023
Treatable traits in interstitial lung diseases: a call to actionFrancesco Amati, Paolo Spagnolo, Justin M Oldham, et al.
Respiratory Research|March 17, 2021
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseasesVincent Cottin, Luca Richeldi, Ivan Rosas, et al.
Respiratory Research|October 23, 2023
Walking the path of treatable traits in interstitial lung diseasesFrancesco Amati, Paolo Spagnolo, Christopher J Ryerson, et al.
The Lancet. Respiratory Medicine|February 8, 2018
Diagnostic criteria for idiopathic pulmonary fibrosis - Authors' replyDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
Infectious Disease Reports|April 25, 2025
Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case SeriesMaria Angela Licata, Giorgio Monteleone, Enrico Schiavi, et al.
Pageof 36